FR2085731B1 - - Google Patents

Info

Publication number
FR2085731B1
FR2085731B1 FR7110219A FR7110219A FR2085731B1 FR 2085731 B1 FR2085731 B1 FR 2085731B1 FR 7110219 A FR7110219 A FR 7110219A FR 7110219 A FR7110219 A FR 7110219A FR 2085731 B1 FR2085731 B1 FR 2085731B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7110219A
Other versions
FR2085731A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2085731A1 publication Critical patent/FR2085731A1/fr
Application granted granted Critical
Publication of FR2085731B1 publication Critical patent/FR2085731B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FR7110219A 1970-03-23 1971-03-23 Expired FR2085731B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2013793A DE2013793C2 (de) 1970-03-23 1970-03-23 N-Methyl-imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2085731A1 FR2085731A1 (fr) 1971-12-31
FR2085731B1 true FR2085731B1 (fr) 1974-09-27

Family

ID=5765958

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7110219A Expired FR2085731B1 (fr) 1970-03-23 1971-03-23

Country Status (21)

Country Link
US (1) US3787415A (fr)
JP (2) JPS5414107B1 (fr)
AT (1) AT301537B (fr)
BE (1) BE764700A (fr)
CA (1) CA971964A (fr)
CH (1) CH558802A (fr)
DE (1) DE2013793C2 (fr)
DK (1) DK143847C (fr)
ES (2) ES389495A1 (fr)
FI (1) FI55338C (fr)
FR (1) FR2085731B1 (fr)
GB (1) GB1288196A (fr)
HU (1) HU162527B (fr)
IE (1) IE35137B1 (fr)
IL (1) IL36272A0 (fr)
NL (1) NL171269C (fr)
NO (1) NO130536C (fr)
SE (1) SE369602B (fr)
SU (1) SU411688A3 (fr)
YU (1) YU34476B (fr)
ZA (1) ZA711268B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928348A (en) * 1970-03-23 1975-12-23 Bayer Ag N-methyl-imidazole derivatives and their production
US4062959A (en) * 1970-03-23 1977-12-13 Bayer Aktiengesellschaft N-methyl-imidazole derivatives for treating mycotic infections
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4384165A (en) * 1981-09-14 1983-05-17 Motorola, Inc. Radio frequency shield with force multiplier interconnection fingers for an electromagnetic gasket
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915465D0 (pt) * 1969-03-07 1973-01-04 Bayer Ag Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica

Also Published As

Publication number Publication date
ZA711268B (en) 1971-11-24
CA971964A (en) 1975-07-29
NO130536C (fr) 1975-01-08
IE35137L (en) 1971-09-23
CH558802A (de) 1975-02-14
IE35137B1 (en) 1975-11-26
GB1288196A (fr) 1972-09-06
DE2013793A1 (de) 1971-10-28
FI55338B (fi) 1979-03-30
DK143847C (da) 1982-04-05
AT301537B (de) 1972-09-11
SU411688A3 (fr) 1974-01-15
BE764700A (fr) 1971-09-23
FR2085731A1 (fr) 1971-12-31
IL36272A0 (en) 1971-04-28
SE369602B (fr) 1974-09-09
DE2013793C2 (de) 1983-02-03
JPS5414107B1 (fr) 1979-06-05
JPS554754B1 (fr) 1980-01-31
ES389495A1 (es) 1973-06-01
NO130536B (fr) 1974-09-23
ES391297A1 (es) 1973-07-01
NL171269C (nl) 1983-03-01
YU34476B (en) 1979-09-10
YU70171A (en) 1979-02-28
DK143847B (da) 1981-10-19
US3787415A (en) 1974-01-22
NL171269B (nl) 1982-10-01
HU162527B (fr) 1973-03-28
FI55338C (fi) 1979-07-10
NL7103889A (fr) 1971-09-27

Similar Documents

Publication Publication Date Title
FR2085731B1 (fr)
AU1473870A (fr)
AU428055B2 (fr)
AU1833270A (fr)
AU1326870A (fr)
AU1716970A (fr)
AU1336970A (fr)
AU1517670A (fr)
AU1343870A (fr)
AU1247570A (fr)
AU2131570A (fr)
AU2144270A (fr)
AU1004470A (fr)
AU1581370A (fr)
AU1591370A (fr)
AU1328670A (fr)
AU1603270A (fr)
AU1689770A (fr)
AU1789870A (fr)
AU1832970A (fr)
AU1235770A (fr)
AU1277070A (fr)
CH563360A5 (fr)
CH1692671A4 (fr)
CH572525A5 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse